

Without treatment, childhood cancer is fatal. However, in regions and settings with access to safe and effective therapies and supportive care, it is eminently survivable. But survival comes at the cost of multi-system, short-term and long-term toxicity and adverse effects. Ensuring that young people with cancer do not just survive, but also thrive, requires the development of less toxic treatments and a better understanding of the unique experiences and needs of the estimated 400 000 children and adolescents who are newly diagnosed with cancer globally each year.
Child & Adolescent Health
|15th Jan, 2026
|The Lancet
Child & Adolescent Health
|15th Jan, 2026
|The Lancet
Child & Adolescent Health
|15th Jan, 2026
|The Lancet
Child & Adolescent Health
|15th Jan, 2026
|The Lancet
Child & Adolescent Health
|15th Jan, 2026
|The Lancet
Child & Adolescent Health
|15th Jan, 2026
|The Lancet
Child & Adolescent Health
|15th Jan, 2026
|The Lancet